| Title | Assessment of cell adhesion, cell surface hydrophobicity, autoaggregation, and lipopolysaccharide-binding properties of live and heat-killed Lactobacillus acidophilus CBT LA1 | ||
| Author | Joo-Hyun Shin, Joong-Su Lee, and Jae-Gu Seo* | ||
| Address | R&D Center, Cell Biotech, Co., Ltd., Gimpo 415-871, Republic of Korea | ||
| Bibliography | Korean Journal of Microbiology, 51(3),241-248, 2015 | ||
| DOI | http://dx.doi.org/10.7845/kjm.2015.5029 | ||
| Key Words | Lactobacillus acidophilus CBT LA1, cell adhesion, heat-killed bacteria, LPS-binding property, pharmabiotic, probiotics | ||
| Abstract | Although studies on probiotics have been performed mostly with viable microbes, the beneficial functions of dead or heat-killed form of probiotic strains have also been examined. In this study, live and heat-killed forms of Lactobacillus acidophilus CBT LA1 were investigated in vitro and in vivo to evaluate the properties necessary for gut barrier protection. Cell surface hydrophobicity (CSH), autoaggregation (AA), cell adhesion, and lipopolysaccharide (LPS)-binding properties were evaluated. In addition, the suppressive effect on LPS-induced interleukin (IL)-8 expression was investigated in HT-29 cells. To identify optimal conditions for CBT LA1 to adhere to HT-29 cells, CBT LA1 cells were heat-treated at 80, 85, 90, 95, 100, or 121°C for 10 min; cells treated at 80°C for 10 min showed the highest adhesion. Heat-killed bacteria at 80°C showed higher levels of LPS-binding, CSH, AA, adhesion to HT-29, and suppression of IL-8 expression than did live CBT LA1. In vivo imaging was performed to evaluate the ability of live or heat-killed CBT LA1 to remove LPS from the intestine in a rat model of infection. At 16 h after infection, fluorescence from FITC-conjugated LPS had mostly disappeared from the intestine of the rats administered with live or heat-killed CBT LA1; the effect was greater with heat-killed CBT LA1 at 80°C. These results suggest that heat-killed CBT LA1 as well as its live form can be applied as a pharmabiotic for protection of the gut barrier. | ||
| Download PDF | 51(3)_07_p.241-248.pdf | ||